[Difficulties in the treatment of tuberculosis in infants]

Shinya Kondo1, Masaki Ito

  • 1Division of Respiratory Diseases, Tokyo Metropolitan Kiyose Children's Hospital, 1-3-1 Umezono, Kiyose-shi, Tokyo 204-0024, Japan. shykondo@chp-kiyose-tokyo.jp

Insights

Infants under one year face high tuberculosis risks due to immature immunity, leading to rapid disease progression and diagnostic challenges. Early diagnosis and treatment are crucial for better outcomes in infant tuberculosis.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Immunology

Context:

  • Childhood tuberculosis incidence is declining in Japan, yet infants under one year remain a high-risk group.
  • Infants exhibit a tuberculosis incidence three times higher than older children.
  • Underdeveloped cell-mediated immunity in infants contributes to rapid disease progression.

Purpose:

  • To highlight the unique challenges in diagnosing and treating tuberculosis in infants under one year.
  • To underscore the increased susceptibility and risk of systemic spread in this age group.
  • To emphasize the importance of early recognition and intervention.

Summary:

  • Infants under one year have underdeveloped immune systems, specifically impaired alveolar macrophage and lymphocyte function, hindering their ability to combat Mycobacterium tuberculosis.
  • This immunological immaturity results in rapid disease progression and systemic spread before treatment can be initiated.
  • Anatomical factors like underdeveloped cranial arteries and narrow cerebrospinal passages increase the risk of neurological complications such as cerebral infarction and hydrocephalus.
  • Diagnostic delays, including false-negative tuberculin skin tests and unclear radiographic findings, further complicate management.
  • Viral infections during treatment can lead to liver dysfunction, disrupting tuberculosis therapy.
  • Recurrence is rare if treatment is completed after one year of age.

Impact:

  • Early diagnosis and prompt treatment initiation are critical for improving prognosis in infants with tuberculosis.
  • Recognizing the heightened susceptibility and diagnostic difficulties in this population is essential for effective public health strategies.
  • Understanding these factors can guide the development of more targeted diagnostic and therapeutic approaches for infant tuberculosis.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
153
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
480
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
751
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
434
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
817